Header Logo

Connection

Xiaoduo Fan to Humans

Back to Details
This is a "connection" page, showing publications Xiaoduo Fan has written about Humans.
Xiaoduo Fan
Connection Strength
0.616
Humans
  1. Cui Z, Yuan Y, Cheung A, Yu T, Hu K, Wang C, Fan X. Acculturation and mental health help-seeking behavior in a community cohort of individuals of Chinese descent. Asian J Psychiatr. 2023 07; 85:103628.
    View in: PubMed
    Score: 0.031
  2. Cheung A, Dutta P, Kovic Y, Stojcevski M, Fan X. Food4Thought: a Medical Trainee-Led, Remotely Delivered Nutrition Outreach Program for Individuals with Serious Mental Illness. Acad Psychiatry. 2023 08; 47(4):406-410.
    View in: PubMed
    Score: 0.030
  3. Cheung A, Agwu V, Stojcevski M, Wood L, Fan X. A Pilot Remote Drama Therapy Program Using the Co-active Therapeutic Theater Model in People with Serious Mental Illness. Community Ment Health J. 2022 11; 58(8):1613-1620.
    View in: PubMed
    Score: 0.029
  4. Fattahi C, Hamada K, Chiang M, Kosuru S, Polavarapu M, Sitthichai R, Fan X. A narrative review of mindfulness-based therapy for schizophrenia, co-occurring substance use and comorbid cardiometabolic problems. Psychiatry Res. 2021 02; 296:113707.
    View in: PubMed
    Score: 0.027
  5. Cheung A, Reid-Varley WB, Chiang M, de Villemejane M, Wood LL, Butler JD, Fan X. Dual diagnosis theater: A pilot drama therapy program for individuals with serious mental illness and substance use disorder. Schizophr Res. 2021 04; 230:95-97.
    View in: PubMed
    Score: 0.026
  6. Oh SJ, Fan X. Current understanding on the role of nitric oxide and therapeutic potential of NO supplementation in schizophrenia. Schizophr Res. 2020 08; 222:23-30.
    View in: PubMed
    Score: 0.026
  7. Hamada K, Fan X. The impact of COVID-19 on individuals living with serious mental illness. Schizophr Res. 2020 08; 222:3-5.
    View in: PubMed
    Score: 0.026
  8. Li H, Ou Y, Liu F, Chen J, Zhao J, Guo W, Fan X. Reduced connectivity in anterior cingulate cortex as an early predictor for treatment response in drug-naive, first-episode schizophrenia: A global-brain functional connectivity analysis. Schizophr Res. 2020 01; 215:337-343.
    View in: PubMed
    Score: 0.024
  9. Chiang M, Lombardi D, Du J, Makrum U, Sitthichai R, Harrington A, Shukair N, Zhao M, Fan X. Methamphetamine-associated psychosis: Clinical presentation, biological basis, and treatment options. Hum Psychopharmacol. 2019 09; 34(5):e2710.
    View in: PubMed
    Score: 0.024
  10. Oh SJ, Fan X. The Possible Role of the Angiotensin System in the Pathophysiology of Schizophrenia: Implications for Pharmacotherapy. CNS Drugs. 2019 06; 33(6):539-547.
    View in: PubMed
    Score: 0.024
  11. Chiang M, Reid-Varley WB, Fan X. Creative art therapy for mental illness. Psychiatry Res. 2019 05; 275:129-136.
    View in: PubMed
    Score: 0.023
  12. Fan X, Copeland P, Nawras S, Harrington A, Freudenreich O, Goff DC, Henderson DC. Adjunctive telmisartan treatment on body metabolism in clozapine or olanzapine treated patients with schizophrenia: a randomized, double blind, placebo controlled trial. Psychopharmacology (Berl). 2019 Jun; 236(6):1949-1957.
    View in: PubMed
    Score: 0.023
  13. Robertson I, Cheung A, Fan X. Insomnia in patients with schizophrenia: current understanding and treatment options. Prog Neuropsychopharmacol Biol Psychiatry. 2019 06 08; 92:235-242.
    View in: PubMed
    Score: 0.023
  14. Wu C, Chiang M, Natarajan R, Fusaro-Davis M, Cimpeanu C, Liu M, Harrington A, Fan X. Pilot lifestyle education intervention for patients with severe mental illness during the inpatient stay. Asian J Psychiatr. 2019 Feb; 40:15-17.
    View in: PubMed
    Score: 0.023
  15. Wu C, Chiang M, Harrington A, Kim S, Ziedonis D, Fan X. Racial disparity in mental disorder diagnosis and treatment between non-hispanic White and Asian American patients in a general hospital. Asian J Psychiatr. 2018 Apr; 34:78-83.
    View in: PubMed
    Score: 0.022
  16. Liu F, Zhang B, Xie L, Ruan Y, Xu X, Zeng Y, Messina L, Zhao J, Fan X. Changes in plasma levels of nitric oxide metabolites and negative symptoms after 16-week minocycline treatment in patients with schizophrenia. Schizophr Res. 2018 09; 199:390-394.
    View in: PubMed
    Score: 0.022
  17. Mitra S, Natarajan R, Ziedonis D, Fan X. Antioxidant and anti-inflammatory nutrient status, supplementation, and mechanisms in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2017 08 01; 78:1-11.
    View in: PubMed
    Score: 0.021
  18. Chiang M, Natarajan R, Fan X. Vitamin D in schizophrenia: a clinical review. Evid Based Ment Health. 2016 Feb; 19(1):6-9.
    View in: PubMed
    Score: 0.019
  19. Rajan S, Zalpuri I, Harrington A, Cimpeanu C, Song X, Fan X. Relationship between serum uric acid level and cardiometabolic risks in nondiabetic patients with schizophrenia. Int Clin Psychopharmacol. 2016 Jan; 31(1):51-6.
    View in: PubMed
    Score: 0.019
  20. Song X, Quan M, Lv L, Li X, Pang L, Kennedy D, Hodge S, Harrington A, Ziedonis D, Fan X. Decreased cortical thickness in drug na?ve first episode schizophrenia: in relation to serum levels of BDNF. J Psychiatr Res. 2015 Jan; 60:22-8.
    View in: PubMed
    Score: 0.017
  21. Sheng J, Li C, Wang J, Chiang C, Harrington A, Yi Z, Liu D, Fan X. Phenotypic characteristics in metabolically healthy but obese patients with schizophrenia. Psychiatry Res. 2014 Dec 15; 220(1-2):71-5.
    View in: PubMed
    Score: 0.017
  22. Fan X, Liu E, Freudenreich O, Copeland P, Hayden D, Ghebremichael M, Cohen B, Ongur D, Goff DC, Henderson DC. No effect of adjunctive, repeated-dose intranasal insulin treatment on psychopathology and cognition in patients with schizophrenia. J Clin Psychopharmacol. 2013 Apr; 33(2):226-30.
    View in: PubMed
    Score: 0.016
  23. Li J, Li X, Liu E, Copeland P, Freudenreich O, Goff DC, Henderson DC, Song X, Fan X. No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophrenia. Schizophr Res. 2013 May; 146(1-3):40-5.
    View in: PubMed
    Score: 0.015
  24. Fan X, Borba CP, Copeland P, Hayden D, Freudenreich O, Goff DC, Henderson DC. Metabolic effects of adjunctive aripiprazole in clozapine-treated patients with schizophrenia. Acta Psychiatr Scand. 2013 Mar; 127(3):217-26.
    View in: PubMed
    Score: 0.015
  25. Zhang X, Zhang X, Cheng S, Fan X, Bao H, Zhou S, Ping J. Spatiotemporal Cell Control via High-Precision Electronic Regulation of Microenvironmental pH. Nano Lett. 2024 12 11; 24(49):15645-15651.
    View in: PubMed
    Score: 0.009
  26. Yuan X, Li X, Kang Y, Pang L, Hei G, Zhang X, Wang S, Zhao X, Zhang S, Tao Q, Zhang L, Zhu Q, Lv L, Fan X, Hu S, Song X. Gut mycobiota dysbiosis in drug-na?ve, first-episode schizophrenia. Schizophr Res. 2022 Dec; 250:76-86.
    View in: PubMed
    Score: 0.008
  27. Li X, Yuan X, Pang L, Zhang S, Li Y, Huang X, Fan X, Song X. The effect of serum lipids and short-chain fatty acids on cognitive functioning in drug-na?ve, first episode schizophrenia patients. Psychiatry Res. 2022 07; 313:114582.
    View in: PubMed
    Score: 0.007
  28. Li M, Qiu Y, Zhang J, Zhang Y, Liu Y, Zhao Y, Jia Q, Fan X, Li J. Improvement of adjunctive berberine treatment on negative symptoms in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2022 Jun; 272(4):633-642.
    View in: PubMed
    Score: 0.007
  29. Li H, Guo W, Liu F, Chen J, Su Q, Zhang Z, Fan X, Zhao J. Enhanced baseline activity in the left ventromedial putamen predicts individual treatment response in drug-naive, first-episode schizophrenia: Results from two independent study samples. EBioMedicine. 2019 Aug; 46:248-255.
    View in: PubMed
    Score: 0.006
  30. Zhu F, Liu F, Guo W, Chen J, Su Q, Zhang Z, Li H, Fan X, Zhao J. Disrupted asymmetry of inter- and intra-hemispheric functional connectivity in patients with drug-naive, first-episode schizophrenia and their unaffected siblings. EBioMedicine. 2018 Oct; 36:429-435.
    View in: PubMed
    Score: 0.006
  31. Yuan X, Zhang P, Wang Y, Liu Y, Li X, Kumar BU, Hei G, Lv L, Huang XF, Fan X, Song X. Changes in metabolism and microbiota after 24-week risperidone treatment in drug na?ve, normal weight patients with first episode schizophrenia. Schizophr Res. 2018 11; 201:299-306.
    View in: PubMed
    Score: 0.006
  32. Du J, Quan M, Zhuang W, Zhong N, Jiang H, Kennedy DN, Harrington A, Ziedonis D, Fan X, Zhao M. Hippocampal volume reduction in female but not male recent abstinent methamphetamine users. Behav Brain Res. 2015 Aug 01; 289:78-83.
    View in: PubMed
    Score: 0.004
  33. Vincenzi B, Stock S, Borba CP, Cleary SM, Oppenheim CE, Petruzzi LJ, Fan X, Copeland PM, Freudenreich O, Cather C, Henderson DC. A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism. Schizophr Res. 2014 Nov; 159(2-3):395-403.
    View in: PubMed
    Score: 0.004
  34. Song X, Fan X, Li X, Kennedy D, Pang L, Quan M, Chen X, Gao J, Zhang W, Zhang J, Lv L. Serum levels of BDNF, folate and homocysteine: in relation to hippocampal volume and psychopathology in drug na?ve, first episode schizophrenia. Schizophr Res. 2014 Oct; 159(1):51-5.
    View in: PubMed
    Score: 0.004
  35. Song X, Li X, Gao J, Zhao J, Li Y, Fan X, Lv L. APOA-I: a possible novel biomarker for metabolic side effects in first episode schizophrenia. PLoS One. 2014; 9(4):e93902.
    View in: PubMed
    Score: 0.004
  36. Ding M, Song X, Zhao J, Gao J, Li X, Yang G, Wang X, Harrington A, Fan X, Lv L. Activation of Th17 cells in drug na?ve, first episode schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jun 03; 51:78-82.
    View in: PubMed
    Score: 0.004
  37. Song X, Fan X, Song X, Zhang J, Zhang W, Li X, Gao J, Harrington A, Ziedonis D, Lv L. Elevated levels of adiponectin and other cytokines in drug na?ve, first episode schizophrenia patients with normal weight. Schizophr Res. 2013 Oct; 150(1):269-73.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.